CRISPR Screens Identify PIK3C2A as a Novel Mediator of EGFR Inhibitor Resistance in Head and Neck Squamous Cell Carcinoma

Documenti analoghi

• Hypoxia and Oxidation Pathway Crosstalk in Head and Neck Squamous Cell Carcinoma
  di: Abdullah A. Adil, et al.
  Pubblicazione: (2026)
• Endoscope‐Assisted Transcervical Resection of Parapharyngeal Space Tumors
  di: Joshua D. Smith, et al.
  Pubblicazione: (2024)
• Pharyngeal Mucosal Margin Vessel Counts Predict Pharyngocutaneous Fistula in Salvage Laryngectomy
  di: Andrew D.P. Prince, et al.
  Pubblicazione: (2024)
• Geographic and Socioeconomic Landscape of Veterans With Head and Neck Cancer
  di: Kristen L. Zayan, et al.
  Pubblicazione: (2025)
• Is Preoperative Chemoprophylaxis Safe for Venous Thromboembolism Prevention in Patients With Head and Neck Cancer?
  di: Heba Isaac, et al.
  Pubblicazione: (2024)